Form 4: Relay Therapeutics Executive Sells Shares to Cover Tax Obligations

Peter Rahmer, Chief Corporate Development Officer of Relay Therapeutics, sold shares to cover income tax withholding obligations related to vesting restricted stock units.

Summary

• Peter Rahmer, Chief Corporate Development Officer of Relay Therapeutics, sold 1,364 shares of common stock on April 28, 2025, at a price of $3.17 per share.
• He also sold 10,739 shares of common stock on April 30, 2025, at a price of $3 per share.
• These sales were to cover income tax withholding obligations upon the vesting of restricted stock units (RSUs).
• Rahmer had no discretion over these sales, which were transacted according to Relay Therapeutics' policies regarding RSU vesting.
• Following these transactions, Rahmer beneficially owns 390,081 shares, including shares underlying RSUs.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction (selling shares to cover tax obligations) and doesn't indicate any significant positive or negative sentiment.

Industry Context

Sales of shares to cover tax obligations upon RSU vesting are a common practice among company executives.

Stakeholder Impact

• The sale of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.

Key Dates

Keywords

Relay Therapeutics, RLAY, Peter Rahmer, stock sale, Form 4, insider trading, RSU vesting, tax obligations, Chief Corporate Development Officer